 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[34m                Passages:[0m
[34m                [0m[1;34m1[0m[34m. Drug DOXEPIN HCL: The FDAHandler has indicated that the FDA label for Doxepin HCL does not specify whether it increases or decreases the risk of myocardial infarction. This suggests[0m
[34mthat there may not be any verified effect on the risk of myocardial infarction, or that such an effect has not been sufficiently studied or documented to be included in the label.[0m

[34m DO-NOT-KNOW[0m

[34mThe FDA label for Doxepin HCL does not provide information on whether it increases or decreases the risk of myocardial infarction. Therefore, I cannot provide a definitive answer to this question [0m
[34mbased on the FDA label data.[0m
[1;34m2[0m[34m. Drug DESIPRAMINE: DESIPRAMINE is associated with an increased risk of myocardial infarction, especially in patients in the acute recovery period following a myocardial infarction or those with [0m
[34mcardiovascular disease. This is based on the information provided by FDAHandler, which indicates that DESIPRAMINE is contraindicated in the acute recovery period following myocardial infarction and [0m
[34mthat extreme caution is advised when it is given to patients with cardiovascular disease due to the possibility of conduction defects, arrhythmias, tachycardias, strokes, and acute myocardial [0m
[34minfarction.[0m
[1;34m3[0m[34m. Drug AMITRIPTYLINE HCL: AMITRIPTYLINE HCL has been reported to be associated with an increased risk of myocardial infarction, as indicated in the adverse reactions section of its drug label.[0m
[34m                ---------[0m
[34m                Does the tricyclic antidepressant category of drugs increase the risk of[0m
[34m                myocardial infarction, decrease it, or is there no clear effect?[0m
[34m            [0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.AGENT [0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"final_answer"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"question"[0m[32m: [0m[32m"Does the tricyclic antidepressant category of drugs increase the risk of myocardial infarction, decrease it, or is there no clear effect?"[0m[32m,[0m
[32m    [0m[32m"steps"[0m[32m: [0m[1;32m[[0m
[32m      [0m[32m"Passage 1 indicates that for Doxepin HCL, there is no specified effect on the risk of myocardial infarction according to the FDA label."[0m[32m,[0m
[32m      [0m[32m"Passage 2 states that Desipramine is associated with an increased risk of myocardial infarction, especially in certain patients, according to FDAHandler."[0m[32m,[0m
[32m      [0m[32m"Passage 3 reports that Amitriptyline HCL is associated with an increased risk of myocardial infarction as indicated in the drug label."[0m[32m,[0m
[32m      [0m[32m"Given that two out of the three drugs mentioned [0m[32m([0m[32mDesipramine and Amitriptyline HCL[0m[32m)[0m[32m are associated with an increased risk, and one drug [0m[32m([0m[32mDoxepin HCL[0m[32m)[0m[32m has no specified effect, it can be inferred[0m
[32mthat the tricyclic antidepressant category has a potential to increase the risk of myocardial infarction."[0m
[32m    [0m[1;32m][0m[32m,[0m
[32m    [0m[32m"answer"[0m[32m: [0m[32m"increase"[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [31m__PASS__:Critic[0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0mEntity.LLM[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m[[0m[32mCANNOT RESPOND[0m[1;32m][0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"final_answer"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"question"[0m[34m: [0m[34m"Does the tricyclic antidepressant category of drugs increase the risk of myocardial infarction, decrease it, or is there no clear effect?"[0m[34m,[0m
[34m    [0m[34m"steps"[0m[34m: [0m[1;34m[[0m
[34m      [0m[34m"Passage 1 indicates that for Doxepin HCL, there is no specified effect on the risk of myocardial infarction according to the FDA label."[0m[34m,[0m
[34m      [0m[34m"Passage 2 states that Desipramine is associated with an increased risk of myocardial infarction, especially in certain patients, according to FDAHandler."[0m[34m,[0m
[34m      [0m[34m"Passage 3 reports that Amitriptyline HCL is associated with an increased risk of myocardial infarction as indicated in the drug label."[0m[34m,[0m
[34m      [0m[34m"Given that two out of the three drugs mentioned [0m[34m([0m[34mDesipramine and Amitriptyline HCL[0m[34m)[0m[34m are associated with an increased risk, and one drug [0m[34m([0m[34mDoxepin HCL[0m[34m)[0m[34m has no specified effect, it can be inferred[0m
[34mthat the tricyclic antidepressant category has a potential to increase the risk of myocardial infarction."[0m
[34m    [0m[1;34m][0m[34m,[0m
[34m    [0m[34m"answer"[0m[34m: [0m[34m"increase"[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"final_answer"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Question: Does the tricyclic antidepressant category of drugs increase the risk of myocardial infarction, decrease it, or is there no clear effect?[0m
[31m        -----[0m
[31m        Reasoning:[0m
[31m        [0m[1;31m1[0m[31m. Passage [0m[1;31m1[0m[31m indicates that for Doxepin HCL, there is no specified effect on the risk of myocardial infarction according to the FDA label.[0m
[1;31m2[0m[31m. Passage [0m[1;31m2[0m[31m states that Desipramine is associated with an increased risk of myocardial infarction, especially in certain patients, according to FDAHandler.[0m
[1;31m3[0m[31m. Passage [0m[1;31m3[0m[31m reports that Amitriptyline HCL is associated with an increased risk of myocardial infarction as indicated in the drug label.[0m
[1;31m4[0m[31m. Given that two out of the three drugs mentioned [0m[1;31m([0m[31mDesipramine and Amitriptyline HCL[0m[1;31m)[0m[31m are associated with an increased risk, and one drug [0m[1;31m([0m[31mDoxepin HCL[0m[1;31m)[0m[31m has no specified effect, it can be inferred [0m
[31mthat the tricyclic antidepressant category has a potential to increase the risk of myocardial infarction.[0m
[31m        -----[0m
[31m        Final answer: increase[0m
[31m        [0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m
 [1m([0mCritic[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"feedback"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"critique"[0m[32m: [0m[32m"The reasoning process is generally sound, but it lacks precision in expressing the degree of certainty and the magnitude of change in risk. The evidence from two out of three drugs in[0m
[32mthe tricyclic antidepressant category suggests an increased risk of myocardial infarction. However, the reasoning does not specify the degree of certainty or the magnitude of the increased risk. It [0m
[32mwould be more accurate to say that there is evidence suggesting an increased risk of myocardial infarction with the use of some tricyclic antidepressants, but the degree of risk increase and the level[0m
[32mof certainty should be clarified based on the strength and consistency of the evidence provided in the passages."[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m<[0m[1;31mDONE[0m[1;31m>[0m[31m __PASS__[0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Critic [0m [1;34mEntity.USER[0m[1m([0m    Critic[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"feedback"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"critique"[0m[34m: [0m[34m"The reasoning process is generally sound, but it lacks precision in expressing the degree of certainty and the magnitude of change in risk. The evidence from two out of three drugs in[0m
[34mthe tricyclic antidepressant category suggests an increased risk of myocardial infarction. However, the reasoning does not specify the degree of certainty or the magnitude of the increased risk. It [0m
[34mwould be more accurate to say that there is evidence suggesting an increased risk of myocardial infarction with the use of some tricyclic antidepressants, but the degree of risk increase and the level[0m
[34mof certainty should be clarified based on the strength and consistency of the evidence provided in the passages."[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"feedback"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Feedback: The reasoning process is generally sound, but it lacks precision in expressing the degree of certainty and the magnitude of change in risk. The evidence from two out of three drugs [0m
[31min the tricyclic antidepressant category suggests an increased risk of myocardial infarction. However, the reasoning does not specify the degree of certainty or the magnitude of the increased risk. It[0m
[31mwould be more accurate to say that there is evidence suggesting an increased risk of myocardial infarction with the use of some tricyclic antidepressants, but the degree of risk increase and the level[0m
[31mof certainty should be clarified based on the strength and consistency of the evidence provided in the passages.[0m

[31m        If any flaws in the reasoning used to produce your[0m
[31m        answer were identified, you must try again.[0m
[31m        [0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.USER [0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"final_answer"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"question"[0m[32m: [0m[32m"Does the tricyclic antidepressant category of drugs increase the risk of myocardial infarction, decrease it, or is there no clear effect?"[0m[32m,[0m
[32m    [0m[32m"steps"[0m[32m: [0m[1;32m[[0m
[32m      [0m[32m"Passage 1 indicates that for Doxepin HCL, there is no specified effect on the risk of myocardial infarction according to the FDA label, which suggests a lack of strong evidence for an effect."[0m[32m,[0m
[32m      [0m[32m"Passage 2 states that Desipramine is associated with an increased risk of myocardial infarction, especially in patients with cardiovascular disease or in the acute recovery period following a [0m
[32mmyocardial infarction. This suggests a clear contraindication and a recognized risk increase."[0m[32m,[0m
[32m      [0m[32m"Passage 3 reports that Amitriptyline HCL is associated with an increased risk of myocardial infarction as indicated in the adverse reactions section of its drug label, which also suggests an [0m
[32mincreased risk."[0m[32m,[0m
[32m      [0m[32m"Given that two out of the three drugs mentioned [0m[32m([0m[32mDesipramine and Amitriptyline HCL[0m[32m)[0m[32m are associated with an increased risk, and one drug [0m[32m([0m[32mDoxepin HCL[0m[32m)[0m[32m has no specified effect, it can be inferred[0m
[32mthat there is evidence suggesting an increased risk of myocardial infarction with the use of some tricyclic antidepressants. However, the degree of risk increase and the level of certainty should be [0m
[32mclarified based on the strength and consistency of the evidence provided."[0m
[32m    [0m[1;32m][0m[32m,[0m
[32m    [0m[32m"answer"[0m[32m: [0m[32m"increase"[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [31m__PASS__:Critic[0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0mEntity.LLM[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m[[0m[32mCANNOT RESPOND[0m[1;32m][0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"final_answer"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"question"[0m[34m: [0m[34m"Does the tricyclic antidepressant category of drugs increase the risk of myocardial infarction, decrease it, or is there no clear effect?"[0m[34m,[0m
[34m    [0m[34m"steps"[0m[34m: [0m[1;34m[[0m
[34m      [0m[34m"Passage 1 indicates that for Doxepin HCL, there is no specified effect on the risk of myocardial infarction according to the FDA label, which suggests a lack of strong evidence for an effect."[0m[34m,[0m
[34m      [0m[34m"Passage 2 states that Desipramine is associated with an increased risk of myocardial infarction, especially in patients with cardiovascular disease or in the acute recovery period following a [0m
[34mmyocardial infarction. This suggests a clear contraindication and a recognized risk increase."[0m[34m,[0m
[34m      [0m[34m"Passage 3 reports that Amitriptyline HCL is associated with an increased risk of myocardial infarction as indicated in the adverse reactions section of its drug label, which also suggests an [0m
[34mincreased risk."[0m[34m,[0m
[34m      [0m[34m"Given that two out of the three drugs mentioned [0m[34m([0m[34mDesipramine and Amitriptyline HCL[0m[34m)[0m[34m are associated with an increased risk, and one drug [0m[34m([0m[34mDoxepin HCL[0m[34m)[0m[34m has no specified effect, it can be inferred[0m
[34mthat there is evidence suggesting an increased risk of myocardial infarction with the use of some tricyclic antidepressants. However, the degree of risk increase and the level of certainty should be [0m
[34mclarified based on the strength and consistency of the evidence provided."[0m
[34m    [0m[1;34m][0m[34m,[0m
[34m    [0m[34m"answer"[0m[34m: [0m[34m"increase"[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"final_answer"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Question: Does the tricyclic antidepressant category of drugs increase the risk of myocardial infarction, decrease it, or is there no clear effect?[0m
[31m        -----[0m
[31m        Reasoning:[0m
[31m        [0m[1;31m1[0m[31m. Passage [0m[1;31m1[0m[31m indicates that for Doxepin HCL, there is no specified effect on the risk of myocardial infarction according to the FDA label, which suggests a lack of strong evidence for an [0m
[31meffect.[0m
[1;31m2[0m[31m. Passage [0m[1;31m2[0m[31m states that Desipramine is associated with an increased risk of myocardial infarction, especially in patients with cardiovascular disease or in the acute recovery period following a [0m
[31mmyocardial infarction. This suggests a clear contraindication and a recognized risk increase.[0m
[1;31m3[0m[31m. Passage [0m[1;31m3[0m[31m reports that Amitriptyline HCL is associated with an increased risk of myocardial infarction as indicated in the adverse reactions section of its drug label, which also suggests an [0m
[31mincreased risk.[0m
[1;31m4[0m[31m. Given that two out of the three drugs mentioned [0m[1;31m([0m[31mDesipramine and Amitriptyline HCL[0m[1;31m)[0m[31m are associated with an increased risk, and one drug [0m[1;31m([0m[31mDoxepin HCL[0m[1;31m)[0m[31m has no specified effect, it can be inferred [0m
[31mthat there is evidence suggesting an increased risk of myocardial infarction with the use of some tricyclic antidepressants. However, the degree of risk increase and the level of certainty should be [0m
[31mclarified based on the strength and consistency of the evidence provided.[0m
[31m        -----[0m
[31m        Final answer: increase[0m
[31m        [0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m
 [1m([0mCritic[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"feedback"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"critique"[0m[32m: [0m[32m"The revised reasoning is more precise in acknowledging the lack of strong evidence for an effect with Doxepin HCL and recognizing the increased risk associated with Desipramine and [0m
[32mAmitriptyline HCL. However, the reasoning could still be improved by explicitly stating the degree of certainty, which is not clearly expressed. The magnitude of the risk increase is also not [0m
[32mquantified. It would be more accurate to state that there is a probable increase in the risk of myocardial infarction associated with the use of tricyclic antidepressants, based on the evidence from [0m
[32mtwo out of three drugs in the category, but the overall magnitude of this risk increase across the entire drug category cannot be determined from the information provided."[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m<[0m[1;31mDONE[0m[1;31m>[0m[31m __PASS__[0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Critic [0m [1;34mEntity.USER[0m[1m([0m    Critic[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"feedback"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"critique"[0m[34m: [0m[34m"The revised reasoning is more precise in acknowledging the lack of strong evidence for an effect with Doxepin HCL and recognizing the increased risk associated with Desipramine and [0m
[34mAmitriptyline HCL. However, the reasoning could still be improved by explicitly stating the degree of certainty, which is not clearly expressed. The magnitude of the risk increase is also not [0m
[34mquantified. It would be more accurate to state that there is a probable increase in the risk of myocardial infarction associated with the use of tricyclic antidepressants, based on the evidence from [0m
[34mtwo out of three drugs in the category, but the overall magnitude of this risk increase across the entire drug category cannot be determined from the information provided."[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"feedback"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Feedback: The revised reasoning is more precise in acknowledging the lack of strong evidence for an effect with Doxepin HCL and recognizing the increased risk associated with Desipramine and [0m
[31mAmitriptyline HCL. However, the reasoning could still be improved by explicitly stating the degree of certainty, which is not clearly expressed. The magnitude of the risk increase is also not [0m
[31mquantified. It would be more accurate to state that there is a probable increase in the risk of myocardial infarction associated with the use of tricyclic antidepressants, based on the evidence from [0m
[31mtwo out of three drugs in the category, but the overall magnitude of this risk increase across the entire drug category cannot be determined from the information provided.[0m

[31m        If any flaws in the reasoning used to produce your[0m
[31m        answer were identified, you must try again.[0m
[31m        [0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.USER [0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"final_answer"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"question"[0m[32m: [0m[32m"Does the tricyclic antidepressant category of drugs increase the risk of myocardial infarction, decrease it, or is there no clear effect?"[0m[32m,[0m
[32m    [0m[32m"steps"[0m[32m: [0m[1;32m[[0m
[32m      [0m[32m"Passage 1 indicates that for Doxepin HCL, there is no specified effect on the risk of myocardial infarction according to the FDA label, which suggests a lack of strong evidence for an effect or[0m
[32mthat it has not been sufficiently studied."[0m[32m,[0m
[32m      [0m[32m"Passage 2 states that Desipramine is associated with an increased risk of myocardial infarction, especially in patients with cardiovascular disease or in the acute recovery period following a [0m
[32mmyocardial infarction. This suggests a clear contraindication and a recognized risk increase, indicating a probable increase in risk for these patients."[0m[32m,[0m
[32m      [0m[32m"Passage 3 reports that Amitriptyline HCL is associated with an increased risk of myocardial infarction as indicated in the adverse reactions section of its drug label, which also suggests an [0m
[32mincreased risk."[0m[32m,[0m
[32m      [0m[32m"Given that two out of the three drugs mentioned [0m[32m([0m[32mDesipramine and Amitriptyline HCL[0m[32m)[0m[32m are associated with an increased risk, and one drug [0m[32m([0m[32mDoxepin HCL[0m[32m)[0m[32m has no specified effect, it can be inferred[0m
[32mthat there is a probable increase in the risk of myocardial infarction associated with the use of some tricyclic antidepressants. However, the overall magnitude of this risk increase across the entire[0m
[32mdrug category cannot be determined from the information provided. The degree of certainty is moderate, given that the increased risk is not reported for all drugs in the category."[0m
[32m    [0m[1;32m][0m[32m,[0m
[32m    [0m[32m"answer"[0m[32m: [0m[32m"increase"[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [31m__PASS__:Critic[0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0mEntity.LLM[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m[[0m[32mCANNOT RESPOND[0m[1;32m][0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"final_answer"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"question"[0m[34m: [0m[34m"Does the tricyclic antidepressant category of drugs increase the risk of myocardial infarction, decrease it, or is there no clear effect?"[0m[34m,[0m
[34m    [0m[34m"steps"[0m[34m: [0m[1;34m[[0m
[34m      [0m[34m"Passage 1 indicates that for Doxepin HCL, there is no specified effect on the risk of myocardial infarction according to the FDA label, which suggests a lack of strong evidence for an effect or[0m
[34mthat it has not been sufficiently studied."[0m[34m,[0m
[34m      [0m[34m"Passage 2 states that Desipramine is associated with an increased risk of myocardial infarction, especially in patients with cardiovascular disease or in the acute recovery period following a [0m
[34mmyocardial infarction. This suggests a clear contraindication and a recognized risk increase, indicating a probable increase in risk for these patients."[0m[34m,[0m
[34m      [0m[34m"Passage 3 reports that Amitriptyline HCL is associated with an increased risk of myocardial infarction as indicated in the adverse reactions section of its drug label, which also suggests an [0m
[34mincreased risk."[0m[34m,[0m
[34m      [0m[34m"Given that two out of the three drugs mentioned [0m[34m([0m[34mDesipramine and Amitriptyline HCL[0m[34m)[0m[34m are associated with an increased risk, and one drug [0m[34m([0m[34mDoxepin HCL[0m[34m)[0m[34m has no specified effect, it can be inferred[0m
[34mthat there is a probable increase in the risk of myocardial infarction associated with the use of some tricyclic antidepressants. However, the overall magnitude of this risk increase across the entire[0m
[34mdrug category cannot be determined from the information provided. The degree of certainty is moderate, given that the increased risk is not reported for all drugs in the category."[0m
[34m    [0m[1;34m][0m[34m,[0m
[34m    [0m[34m"answer"[0m[34m: [0m[34m"increase"[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"final_answer"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Question: Does the tricyclic antidepressant category of drugs increase the risk of myocardial infarction, decrease it, or is there no clear effect?[0m
[31m        -----[0m
[31m        Reasoning:[0m
[31m        [0m[1;31m1[0m[31m. Passage [0m[1;31m1[0m[31m indicates that for Doxepin HCL, there is no specified effect on the risk of myocardial infarction according to the FDA label, which suggests a lack of strong evidence for an [0m
[31meffect or that it has not been sufficiently studied.[0m
[1;31m2[0m[31m. Passage [0m[1;31m2[0m[31m states that Desipramine is associated with an increased risk of myocardial infarction, especially in patients with cardiovascular disease or in the acute recovery period following a [0m
[31mmyocardial infarction. This suggests a clear contraindication and a recognized risk increase, indicating a probable increase in risk for these patients.[0m
[1;31m3[0m[31m. Passage [0m[1;31m3[0m[31m reports that Amitriptyline HCL is associated with an increased risk of myocardial infarction as indicated in the adverse reactions section of its drug label, which also suggests an [0m
[31mincreased risk.[0m
[1;31m4[0m[31m. Given that two out of the three drugs mentioned [0m[1;31m([0m[31mDesipramine and Amitriptyline HCL[0m[1;31m)[0m[31m are associated with an increased risk, and one drug [0m[1;31m([0m[31mDoxepin HCL[0m[1;31m)[0m[31m has no specified effect, it can be inferred [0m
[31mthat there is a probable increase in the risk of myocardial infarction associated with the use of some tricyclic antidepressants. However, the overall magnitude of this risk increase across the entire[0m
[31mdrug category cannot be determined from the information provided. The degree of certainty is moderate, given that the increased risk is not reported for all drugs in the category.[0m
[31m        -----[0m
[31m        Final answer: increase[0m
[31m        [0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m
 [1m([0mCritic[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"feedback"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"critique"[0m[32m: [0m[32m""[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m<[0m[1;31mDONE[0m[1;31m>[0m[31m __PASS__[0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Critic [0m [1;34mEntity.USER[0m[1m([0m    Critic[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"feedback"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"critique"[0m[34m: [0m[34m""[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"feedback"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [31mYour reasoning is valid, no feedback was [0m
[31mprovided.[0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.USER [0m
 [1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mcategory_effect_tool[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"category_effect_tool"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"label"[0m[32m: [0m[32m"increase"[0m[32m,[0m
[32m    [0m[32m"confidence"[0m[32m: [0m[1;32m0.7[0m[32m,[0m
[32m    [0m[32m"probability"[0m[32m: [0m[1;32m0.6[0m[32m,[0m
[32m    [0m[32m"frequency"[0m[32m: [0m[32m"rare"[0m[32m,[0m
[32m    [0m[32m"evidence"[0m[32m: [0m[32m"weak"[0m[32m,[0m
[32m    [0m[32m"justification"[0m[32m: [0m[32m"Two out of the three tricyclic antidepressants mentioned [0m[32m([0m[32mDesipramine and Amitriptyline HCL[0m[32m)[0m[32m are associated with an increased risk of myocardial infarction, while one [0m[32m([0m[32mDoxepin [0m
[32mHCL[0m[32m)[0m[32m has no specified effect. The increased risk is not reported for all drugs in the category, indicating a moderate degree of certainty. The magnitude of risk increase and the frequency of such [0m
[32mevents are not quantified in the passages, but given the specific contraindications and warnings, it is likely that the risk increase is clinically significant but probably rare. The evidence is [0m
[32mconsidered weak because it is not consistent across the entire category and is based on label warnings and adverse reaction sections rather than systematic studies."[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0moverall-effect-myocardial infarction-tricyclic antidepressant[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mcategory_effect_tool[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m<[0m[1;31mDONE[0m[1;31m>[0m
